Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.

The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.

Vueway® (Gadopiclenol) Vueway® (Gadopiclenol) ist ein hochstabiles makrozyklisches MRT Kontrastmittel. Finden Sie weitere Fachinformationen auf dieser Seite.

ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.

Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.

Which value does Bracco give to education? At ECR2024, Francesca Pelliconi, Strategy & Operations Director, Global Marketing at Bracco Imaging, engaged in a conversation with Guido Gebhardt of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends. 

The Bracco Group announces the newly-created Bracco Japan The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai

What does innovation mean to Bracco? At ECR2024, Fabio Tedoldi, Head of Global Research & Development at Bracco Imaging, engaged in a conversation on Innovation with Mélisande Rouger of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends.